These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36494261)

  • 1. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
    Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
    J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
    Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
    J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study.
    Liposits G; Skuladottir H; Ryg J; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Johansen JS; Glimelius B; Sorbye H; Pfeiffer P
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
    Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
    J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study.
    Jespersen E; Winther SB; Minet LR; Möller S; Pfeiffer P
    J Geriatr Oncol; 2021 May; 12(4):578-584. PubMed ID: 33830020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
    Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical decline, falls, and hospitalization among vulnerable older patients in the trajectory of colorectal cancer treatment.
    Lund CM; Nielsen DL; Schultz M; Dolin TG
    J Geriatr Oncol; 2024 Sep; 15(7):101820. PubMed ID: 38955634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS).
    Decoster L; Kenis C; Naessens B; Houbier G; De Man M; Lambrecht G; Monsaert E; Moons V; Vergauwe P; Prenen H; Van Cutsem E; Wildiers H
    J Geriatr Oncol; 2018 Mar; 9(2):93-101. PubMed ID: 29133190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
    Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9.
    Winther SB; Österlund P; Berglund Å; Glimelius B; Qvortrup C; Sorbye H; Pfeiffer P;
    BMC Cancer; 2017 Aug; 17(1):548. PubMed ID: 28814275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of functional status in older patients treated with palbociclib for advanced breast cancer.
    Karuturi MS; Cappelleri JC; Blum JL; Patel K; Telivala B; McCune S; Cuevas JD; Lakhanpal S; Montelongo MZ; Wang Y; Tripathy D; Rocque GB
    J Geriatr Oncol; 2024 Jan; 15(1):101670. PubMed ID: 38061288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer.
    Kim VS; Yang H; Timilshina N; Breunis H; Emmenegger U; Gregg R; Hansen AR; Tomlinson G; Alibhai SMH
    J Geriatr Oncol; 2023 Mar; 14(2):101417. PubMed ID: 36682218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial.
    Pearce J; Swinson D; Cairns D; Nair S; Baxter M; Petty R; Seymour M; Hall P; Velikova G;
    J Geriatr Oncol; 2022 Apr; 13(3):287-293. PubMed ID: 34955446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survival.
    Rao AR; Noronha V; Ramaswamy A; Kumar A; Pillai A; Gattani S; Sehgal A; Kumar S; Castelino R; Pearce J; Dhekale R; Jagtap P; Tripathi V; Satamkar S; Krishnamurthy J; Mahajan S; Daptardar A; Sonkusare L; Deodhar J; Ansari N; Vagal M; Mahajan P; Timmanpyati S; Nookala M; Chitre A; Kapoor A; Gota V; Banavali S; Badwe RA; Prabhash K
    J Geriatr Oncol; 2024 Apr; 15(3):101736. PubMed ID: 38428186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.
    Agemi Y; Shimokawa T; Sasaki J; Miyazaki K; Misumi Y; Sato A; Aida S; Ishii M; Nakamura Y; Naoki K; Okamoto H
    PLoS One; 2019; 14(1):e0210499. PubMed ID: 30653558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study.
    Anic K; Altehoefer C; Krajnak S; Schmidt MW; Schwab R; Linz VC; Schmidt M; Westphalen C; Hartmann EK; Hasenburg A; Battista MJ
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):851-863. PubMed ID: 35212815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group.
    Giessen C; Graeven U; Laubender RP; Modest DP; Schulz C; Porschen R; Schmiegel W; Reinacher-Schick A; Hegewisch-Becker S; Stintzing S; Heinemann V
    Ann Oncol; 2013 Dec; 24(12):3051-5. PubMed ID: 24130263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.